Neutrophil extracellular traps can activate alternative complement pathways

Clinical and Experimental Immunology

Volumn 181, Issue 3, 2015, Pages 518-527

  Wang, H ^a,b,c,d   Wang, C ^a,b,c,d   Zhao, M H ^a,b,c,d   Chen, M ^a,b,c,d  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d Tsinghua University   (China)

Author keywords

Alternative complement pathway; ANCA; Complement; Neutrophil extracellular traps; Vasculitis

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C5A; DEOXYRIBONUCLEASE I; ETHYLENE GLYCOL; IMMUNOGLOBULIN G; PROPERDIN; TUMOR NECROSIS FACTOR ALPHA; COMPLEMENT COMPONENT C3B; COMPLEMENT MEMBRANE ATTACK COMPLEX; EGTAZIC ACID; NEUTROPHIL CYTOPLASMIC ANTIBODY; SC5B-9 PROTEIN COMPLEX;

ANCA ASSOCIATED VASCULITIS; ARTICLE; CELL ADHESION; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPOSITION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR TRAP; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VITRO STUDY; NEUTROPHIL; PATHOGENESIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; BLOOD; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; HEAT; IMMUNOLOGY; METABOLISM; SERUM;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CELLS, CULTURED; COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C3B; COMPLEMENT C5A; COMPLEMENT FACTOR B; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, ALTERNATIVE; EGTAZIC ACID; EXTRACELLULAR TRAPS; HOT TEMPERATURE; HUMANS; IMMUNOBLOTTING; MICROSCOPY, CONFOCAL; NEUTROPHILS; PROPERDIN; SERUM;

EID: 84939262939     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12654     Document Type: Article

References (35)

1. Jennette JC, Falk RJ, Bacon PA et al. 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65:1-11.
2. Chen M, Yu F, Zhang Y, Zhao MH. Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore) 2008; 87:203-9.
3. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-19.
4. Kessenbrock K, Krumbholz M, Schonermarck U et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009; 15:623-5.
5. Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449:564-9.
6. Sangaletti S, Tripodo C, Chiodoni C et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood 2012; 120:3007-18.
7. Xing GQ, Chen M, Liu G, Zheng X, E J, Zhao MH. Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis. J Clin Immunol 2010; 30:144-56.
8. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007; 170:52-64.
9. Gou SJ, Yuan J, Chen M, Yu F, Zhao MH. Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 2013; 83:129-37.
10. Xing GQ, Chen M, Liu G et al. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 2009; 29:282-91.
11. Huugen D, van Esch A, Xiao H et al. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 2007; 71:646-54.
12. Leffler J, Martin M, Gullstrand B et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 2012; 188:3522-31.
13. Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun 2010; 34:J276-86.
14. Van Timmeren MM, Chen M, Heeringa P. Review article: pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Nephrology (Carlton) 2009; 14:16-25.
15. Schreiber A, Rolle S, Peripelittchenko L et al. Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis. Kidney Int 2010; 77:118-28.
16. Choi M, Rolle S, Rane M, Haller H, Luft FC, Kettritz R. Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Kidney Int 2003; 63:96-106.
17. Aga E, Katschinski DM, van Zandbergen G et al. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol 2002; 169:898-905.
18. Jiang H, Wang Z, Serra D, Frank MM, Amalfitano A. Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies. Mol Ther 2004; 10:1140-2.
19. Nakao M, Miura C, Itoh S et al. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface. Fish Shellfish Immunol 2004; 16:139-49.
20. Nakazawa D, Tomaru U, Suzuki A et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2012; 64:3779-87.
21. Saffarzadeh M, Juenemann C, Queisser MA et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLOS ONE 2012; 7:e32366.
22. Mershon-Shier KL, Vasuthasawat A, Takahashi K, Morrison SL, Beenhouwer DO. In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways. Mol Immunol 2011; 48:2009-18.
23. Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 2001; 180:35-48.
24. Nakazawa D, Shida H, Tomaru U et al. Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. J Am Soc Nephrol 2014; 25:990-7.
25. Nakazawa D, Tomaru U, Suzuki A et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2012; 64:3779-87.
26. Camous L, Roumenina L, Bigot S et al. Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood 2011; 117:1340-9.
27. Wirthmueller U, Dewald B, Thelen M et al. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol 1997; 158:4444-51.
28. Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 2009; 20:289-98.
29. Huber-Lang M, Younkin EM, Sarma JV et al. Generation of C5a by phagocytic cells. Am J Pathol 2002; 161:1849-59.
30. Chen M, Xing GQ, Yu F, Liu G, Zhao MH. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant 2009;24:1247-52.
31. Hao J, Meng LQ, Xu PC, Chen M, Zhao MH. p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation. PLOS ONE 2012; 7:e38317.
32. Kambas K, Chrysanthopoulou A, Vassilopoulos D et al. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann Rheum Dis 2014; 73:1854-63.
33. Huber-Lang M, Sarma JV, Zetoune FS et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006; 12:682-7.
34. Krisinger MJ, Goebeler V, Lu Z et al. Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway. Blood 2012; 120:1717-25.
35. O'Flynn J, Dixon KO, Faber Krol MC, Daha MR, van Kooten C. Myeloperoxidase directs properdin-mediated complement activation. J Innate Immun 2014; 6:417-25.